Colorectal cancer, commonly referred to as colon cancer, originates in the colon (large intestine) or rectum, typically as adenomatous polyps. It is unknown what causes cancer yet familial adenomatous polposis (FAP) and hereditary nonpolyposis colorectal cancer (HNPCC) are thought to increase risk of developing colon cancer. HNPCC is also referred to as Lynch Syndrome which can be divided into type I and type II. Individuals with this specific diagnosis are commonly diagnosed at a younger age than those without this condition. However, HNPCC as well as FAP can be screened in genetic testing. Additionally, increasing age, inflammatory intestinal conditions, nationality, low fiber and high fat diet, diabetes, smoking, alcohol, obesity, and a sedentary lifestyle can contribute to its onset. Treatments for colon cancer include surgery, chemotherapy, radiation therapy, and targeted drug therapy.
Hereditary Nonpolyposis Colorectal Cancer Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Hereditary Nonpolyposis Colorectal Cancer below!
For more information on how to use Laverne, please read the How to Guide.
We have 863 products for the study of Hereditary Nonpolyposis Colorectal Cancer that can be applied to Western Blot, Flow Cytometry, Chromatin Immunoprecipitation, Immunocytochemistry/Immunofluorescence, Chromatin Immunoprecipitation (ChIP), Immunohistochemistry from our catalog of antibodies and ELISA kits.